Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-17

FDA Approved: FINGOLIMOD — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA approved Solco Healthcare US, LLC's supplemental application for fingolimod (generic), authorizing a generic product under ANDA208003 for relapsing forms of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD)